NCCLS Guidelines

UPDATED June 2006CLSIGUIDELINESLOCATION Abbreviation Vol No Replaces StatusDateVOL 9 H42-A 17 18 H42-P Dec1998VOL 9 H43-A 17 18 H43-P June1998VOL 8 H44-A2 24 8 H44-A FEB2004Vol 12 H45-A2 25 15 H45-A June2005VOL 7 H47-A 16 3 H28T &H29TJUN1996VOL 11 H49-A 24 23 H49-P JULY2004VOL 8 H51-A 22 20 H51-P SEPT2002VOL 5 H52-A 21 26 H52-P DEC2001VOL 13 H54-A 25 23 H54-P AUG2005VOL 13 H56-A 25 20 Aug2005VOL 2 HS1-A2 24 37 HS1-A Nov2004VOL 6 HS2-A 23 5 HS2-P Feb2003VOL 12 HS3-A 25 5 HS3-P Jan2005VOL 5 HS4-A2 26 15 HS4-A May2006VOL 8 HS5-A2 26 16 HS5-AP May2006STATUSApprovedGuidelineApprovedGuidelineApprovedGuideline –2 nd EditionApprovedGuideline –2 nd EditionApprovedGuidelineApprovedGuidelineApprovedGuidelineApprovedGuidelineApprovedGuidelineProposedGuidelineApprovedGuideline –2 nd EditionApprovedGuidelineApprovedGuidelineApprovedGuideline –2 nd EditionApprovedGuideline –2 nd EditionTITLEClinical Applications of Flow Cytometry: Quality Assurance andImmunophenotyping of LymphocytesClinical Applications of Flow Cytometry: Immunophenotyping ofLeukemic CellsMethods for Reticulocyte Counting (Automated Blood Cell Counters,Flow Cytometry, and Supravital Dyes)Performance of the Bleeding Time TestOne-Stage Prothrombin Time (PT) Test and Activated PartialThromboplastin Time (APTT) TestPoint-Of-Care Monitoring of Anticoagulation TherapyAssays of von Willebrand Factor Antigen and Ristocetic Cofactor ActivityFetal Red Cell DetectionProcedures for Validation of INR and Local Calibration of PT/INRSystemsBody Fluid Analysis for Cellular CompositionA Quality Management System Model for Health CareProvider-Performed Microscopy TestingPulse OximetryApplication of a Quality Management System Model for RespiratoryServicesApplication of a Quality Management System Model for Medical ImagingServices6